Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder
Matters and Issuer Purchases of Equity Securities.
Market for our Common Stock
Our Common Stock is currently
approved for quotation on the OTC Pink Market under the symbol “DROR.” As soon as practicable, and assuming we satisfy all
necessary initial listing requirements, we intend to apply to have our Common Stock listed for trading on The Nasdaq Stock Market, although
we cannot be certain that any such application will be approved.
The following table sets
forth the high and low sale prices for our Common Stock for the periods indicated as reported by OTC. The high and low prices reflect
inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.
Quarter Ended
High
Low
December 31, 2024
$
0.021
$
0.0050
September 30, 2024
$
0.024
$
0.0036
June 30, 2024
$
0.013
$
0.0030
March 31, 2024
$
0.019
$
0.0062
December 31, 2023
$
0.03
$
0.0093
September 30, 2023
$
0.0474
$
0.01
June 30, 2023
$
0.038
$
0.0102
March 31, 2023
$
0.04475
$
0.0085
December 31, 2022
$
0.0275
$
0.009
September 30, 2022
$
0.054
$
0.0211
June 30, 2022
$
0.074
$
0.036
March 31, 2022
$
0.1326
$
0.035
December 31, 2021
$
0.1349
$
0.0811
September 30, 2021
$
0.15
$
0.0801
June 30, 2021
$
0.34
$
0.107
March 30, 2021
$
0.58
$
0.0475
Shareholders of Record
As of February 18, 2025, there
were 235 stockholders of record holding 956,997,116 shares of common stock.
Recent Sales of Unregistered Securities
During the fiscal year ended
December 31, 2024, all sales of equity securities not registered under the Securities Act were included in our Quarterly Reports on Form
10-Q and in our Current Reports on Form 8-K.
Repurchase of Equity Securities
We have no plans, programs
or other arrangements in regard to repurchases of our common stock.
48
Dividends
We have not paid any cash
dividends on shares of our Common Stock to date. It is the present intention of our board of directors to retain future earnings for
the development, operation, and expansion of its business, and our board of directors does not anticipate declaring or paying any cash
dividends for the foreseeable future. The payment of dividends is within the discretion of our board of directors and will be contingent
upon our future revenues and earnings, as well as its capital requirements and general financial condition, and we can give no assurances
that we will ever have excess funds available to pay dividends.
Securities Authorized for Issuance under Equity Compensation Plans
The table below sets forth
certain information as of December 31, 2024 regarding the shares of our Common Stock available for grant or granted under stock option
plans and other compensation arrangements that (i) were adopted by our stockholders and (ii) were not adopted by our stockholder.
Plan Category
Number of
securities
to be
issued upon
exercise of
outstanding
options,
warrants and
rights
Weighted
average
exercise
price of
outstanding
options,
warrants,
and rights
Number of
securities
remaining
available for
future
issuance
under
equity
compensation
plans
(excluding
securities
reflected in
common)
Equity Compensation plans approved by stockholders (1)
184,264,323
$ 0.0037
224,570,065
Equity Compensation plans not approved by stockholders
—
—
—
Total
184,264,323
$ 0.0037
224,570,065
(1)
Represents shares approved
for issuance under the 2021 Plan and the 2023 Plan. All information in this table has been adjusted to give effect to the Share Exchange.
Use of Proceeds from the Sale of Registered Securities
None.
Item 6. [Reserved]